2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans
The agency urges consumers not to purchase these products, which are of unknown quality and may be harmful to their health. Until FDA approval, the drug is likely to find a thriving market online, investigated by users looking to kick-start weight loss or speed up their cuts, and purveyed by middle-man retailers like Jake Terry
10.1016/j.neuroscience.2015.11.010 330
Comparative studies in obese mice showed that AOD-9604 produced slightly greater fat reduction than the unmodified fragment at equivalent doses
Please call ahead
The most commonly reported side effects in Phase 2 trials were gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which were generally mild to moderate and tended to improve over time